Prescribers now provided with enhanced real-time information through state-of the-art technology
Media Contact: LARA Communications 517-373-9280
Email Contact: firstname.lastname@example.org
April 11, 2017 - As part of Michigan’s multi-faceted strategy to prevent opioid abuse, the state has launched a new Michigan Automated Prescription System (MAPS). Appriss Health’s PMP AWARxE, replaces the old MAPS and puts Michigan at the forefront of prescription drug monitoring technology.
Gov. Rick Snyder formed the Michigan Prescription Drug and Opioid Abuse Task Force in June 2015 and one of their key recommendations was to update and replace the problematic MAPS platform. The governor also established the Prescription Drug and Opioid Abuse Commission to continue the work initiated by the task force. In addition to the new system and the work of the commission, the Snyder Administration along with a group of bipartisan legislators, recently unveiled a comprehensive legislative strategy focused on building on the state’s current efforts to tackle the opioid crisis that plagues our communities.
“Replacing the outdated MAPS is central in our fight against the opioid epidemic that has been so tragic for Michigan families,” said Lt. Gov. Brian Calley, who chaired the task force. “The modern system gives prescribers and dispensers state-of-the-art tools to make more informed decisions, intervene earlier and spend additional time with patients and customers."
The new MAPS provides the state’s prescribers with a user-friendly portal, making it more efficient for practitioners to obtain information of controlled substances and Schedule 2-5 drugs that have been dispensed. Prescribers include dentists, physicians (MD, DO), physician assistants, podiatrists, optometrists, veterinarians and advanced practice registered nurses under delegation. The MAPS portal is administered by the Department of Licensing and Regulatory Affairs’ (LARA) Bureau of Professional Licensing.
“The successful and timely launch of the new MAPS was a direct result of the collaborative efforts between the State of Michigan, legislators and the medical community,” said LARA Director Shelly Edgerton. “We’re hopeful prescribers and practitioners from across the state will utilize this powerful system to effectively measure a patient’s potential danger in abusing these addictive drugs.”
A $2.47 million appropriation from the state legislature gave LARA the opportunity to begin replacing the old MAPS in 2016 and a $2.02 million appropriation was later granted for ongoing maintenance and support of the new system. LARA’s six-month implementation culminated with the new system’s launch on April 4, 2017.
“We are proud to partner with the State of Michigan on this system that will provide practitioners with a widespread exchange of information and advanced analytics to efficiently identify patient drug abuse,” said Rob Cohen, president of Appriss Health, provider of the nation’s most comprehensive platform for substance use disorders.
Benefits of the new MAPS include:
In partnership with Appriss and the State of Michigan, Kroger Stores’ 105 Michigan pharmacies have fully integrated MAPS data and advanced analytics into their workflow to better address and protect citizens from prescription drug abuse.
“I would like to thank Kroger for their investment and efforts to make it possible for pharmacists and practitioners to access and use MAPS data in their workflow and I am hopeful other large pharmacy chains and hospital systems will also soon fully integrate with the new system,” added Calley.
More information on the new MAPS can be found at the following resources:
About Appriss Health
Appriss Health provides the nation's most comprehensive platform for early identification, prevention and management of substance use disorders. PMP AWARxE is a prescription monitoring solution that provides state government agencies with accurate, real-time data, compliant with their regulations. Active in 43 states and territories, Appriss Health’s prescription monitoring solutions lead the nation in prescription data monitoring.